Network Insights Methodology Get Access

PlocamiumAI

ORG Health Care / Biotechnology Momentum 4.7ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

PlocamiumAI develops artificial intelligence applications for oncology drug discovery and development. The entity appeared in coverage of AstraZeneca-Daiichi's triple-negative breast cancer therapeutic approval, suggesting involvement in computational biology or AI-driven biotech applications.

0.12
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
4.7
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
135
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Connected Entities
FDA China Strait of Hormuz CEO Europe Middle East Washington Gulf President United Kingdom DOD Eli Lilly M&A White House Beijing
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-28 2026-06-11 135 0 Degree Mentions
Signal Decomposition
Attention Cascade
3.333
Narrative Drift
0.000
Spectral Shift
469.243
Sentiment-Momentum Divergence
0.000
Source Concentration
1.000
Peer Comparison
Not yet ranked. Sector-relative scoring requires at least four entities in the same BICS sector with PSI history; this entity does not yet meet the threshold or sits in a sector with insufficient peers.
Network Analysis
135 Degree Centrality
Ego Network (top connections)
FDA (weight 43.0)China (weight 42.0)Strait of Hormuz (weight 31.0)CEO (weight 30.0)Europe (weight 24.0)Middle East (weight 24.0)Washington (weight 20.0)Gulf (weight 19.0) FDAChinaStrait of HormuzCEOEuropeMiddle EastWashingtonGulf PlocamiumAI (degree 135) PlocamiumAI
Centrality History
2026-05-28 2026-06-11 135 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 43 NEW
China 42 NEW
Strait of Hormuz 31 NEW
CEO 30 NEW
Europe 24 NEW
Middle East 24 NEW
Washington 20 NEW
Gulf 19 NEW
President 18 NEW
United Kingdom 17 NEW
DOD 17 NEW
Eli Lilly 16 NEW
M&A 16 NEW
White House 16 NEW
Beijing 15 NEW
Asia 15 NEW
European Union 14 NEW
Brazil 14 NEW
New York 11 NEW
AstraZeneca 10 NEW
Japan 10 NEW
South Korea 10 NEW
North America 10 NEW
Merck 10 NEW
CMS 10 NEW
BBC 9 NEW
Prime Minister 9 NEW
Iran 9 NEW
Mexico 8 NEW
Argentina 8 NEW
Article Coverage (20)
DateLaneTitle
2026-05-29 Healthcare M&A Bain's Swift Exit From Estia Health Signals Shift to Infrastructure Investors For Long-Term Care Assets
2026-05-28 Healthcare M&A Apogee Secures $1.3 Billion From Blackstone as Alternative Capital Reshapes Biotech Financing
2026-05-28 Geopolitics / GCC / LATAM Sanctions Relief Prospects Push Stocks Higher From Gulf to Latin America
2026-05-28 Industrials & Manufacturing Blue Origin Plants 600 Million Dollar Bet on Florida Rocket Manufacturing
2026-05-27 Geopolitics / GCC / LATAM Saudi Arabia Pumps Brakes on Lavish Infrastructure Push Amid Budget Pressures
2026-05-27 FINANCE Iran Diplomacy Breakthrough Lifts Markets From Uncertainty
2026-05-27 Geopolitics / GCC / LATAM Iran Tensions Threaten to Spike Energy Bills Across Latin America
2026-05-27 Healthcare M&A Cencora Poaches CVS Finance Leader to Navigate Prescription Drug Pressures
2026-05-27 Industrials & Manufacturing PMGC Acquires 76-Year-Old Aerospace Supplier as Defense Reshoring Accelerates Manufacturing Consolidation
2026-05-27 Industrials & Manufacturing America's Battery Boom Accelerates, Shattering First Quarter Records
2026-05-27 Healthcare M&A Lenacapavir Arrives in Africa. Now Pharma Dealmakers Hunt For Companies That Can Actually Deliver It
2026-05-27 Industrials & Manufacturing AI's Electricity Demands Force First Major Convergence of Power, Digital Assets
2026-05-26 Healthcare Marketing FDA Blocks Weight-Loss Drugs From Compounding Pharmacies as Supply Concerns Mount
2026-05-26 FINANCE IBM Emerges From Shadows as Trump Bets $1 Billion on Quantum Computing
2026-05-26 Healthcare M&A Triple-Negative Breast Cancer Gets First Real Alternative to Chemo as AstraZeneca-Daiichi Drug Wins Approval
2026-05-26 Industrials & Manufacturing Applied Aerospace to Raise $682.5 Million in IPO as Defense Demand Surges
2026-05-26 FINANCE Stocks Rally to Record Levels While Energy Costs Collapse on Mideast Tensions Ease
2026-05-26 Healthcare Marketing Oura Races Into Public Markets as Wearable Health Trackers Gain Wall Street Appeal
2026-05-25 Healthcare Marketing FDA Approves First Non-Antipsychotic Drug For Dementia Agitation, Reshaping Treatment Options
2026-05-23 Healthcare M&A Merck Lung Cancer Drug Advances as Pharma Faces Parkinson's Setback

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-11 ← Intelligence Network